EGR1 and prostate cancer: For example, STAT3, AP1, AR, ERG, EGR1 and MYC are important TFs that are responsible for the progression of prostate cancer by affecting a wide variety of pathways involved in cell proliferation and differentiation, apoptosis, tumor suppressing and various cell signaling pathway [13–16].